C07D 271/07
With oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms
Official title: with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
C07D271/07 (With oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms) appears on 324 US grants and 266 published applications in this corpus.
Search patents in C07D- Granted patents
- 324
- Published applications
- 266
- Assignees
- 221
- Inventors
- 1,196
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 5 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 6 | 0 |
| 1983 | 10 | 0 |
| 1984 | 6 | 0 |
| 1985 | 5 | 0 |
| 1986 | 1 | 0 |
| 1987 | 6 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 11 | 0 |
| 1991 | 4 | 0 |
| 1992 | 8 | 0 |
| 1993 | 7 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 6 | 0 |
| 1999 | 10 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 1 |
| 2002 | 7 | 15 |
| 2003 | 11 | 11 |
| 2004 | 9 | 15 |
| 2005 | 6 | 18 |
| 2006 | 9 | 13 |
| 2007 | 9 | 12 |
| 2008 | 6 | 9 |
| 2009 | 7 | 14 |
| 2010 | 8 | 14 |
| 2011 | 8 | 4 |
| 2012 | 6 | 5 |
| 2013 | 5 | 8 |
| 2014 | 8 | 15 |
| 2015 | 9 | 12 |
| 2016 | 10 | 10 |
| 2017 | 15 | 12 |
| 2018 | 6 | 11 |
| 2019 | 7 | 6 |
| 2020 | 5 | 10 |
| 2021 | 7 | 13 |
| 2022 | 5 | 7 |
| 2023 | 8 | 11 |
| 2024 | 8 | 10 |
| 2025 | 2 | 6 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oxadiazole compounds for controlling or preventing phytopathogenic fungi14 Jul 2026US 12,677,832 B2Pi Industries Ltd.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications9 Jun 2026US 12,649,712 B2NucMito Pharmaceuticals Co. Ltd.
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Inhibitors of phospholipid synthesis and methods of use3 Feb 2026US 12,540,115 B2The Board of Trustees of the Leland Stanford Junior University
- Urea compound for antagonizing LPA1 receptor24 Jun 2025US 12,338,203 B2Taisho Pharmaceutical Co., Ltd.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
- Fabp4/5 inhibitors, methods of use and methods of making14 May 2026US 2026/0132106 A1Celloram Inc.
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
- Compounds and uses thereof2 Oct 2025US 2025/0304569 A1Janssen Pharmaceutica NV
Most cited
By later US patents
- 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof66US 4,409,214 AFujisawa Pharmaceutical Co., Ltd. · 1983
- Benzamidine derivatives as factor XA inhibitors48US 6,492,368 B1Merck Patent GmbH · 2002
- [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives47US 5,168,103 AAmerican Home Products Corporation · 1992
- Amidino compounds useful as nitric oxide synthase inhibitors41US 6,586,474 B2Pharmacia Corporation · 2003
- 1-heterocycle substituted diarylamines38US 6,545,030 B1Warner-Lambert Company · 2003